Skip to content
10-K

Annual Report

Elanco Animal Health Incorporated ELAN

0001739104-25-000014

← back to feed
Filed
Feb 25, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 20, 2025 494.61M sh
Long Term Debt FY 2024 · Dec 31, 2024 $4.28B
Long Term Debt FY 2024 · Dec 31, 2023 $5.74B
Short Term Debt FY 2024 · Dec 31, 2024 $44M
Short Term Debt FY 2024 · Dec 31, 2023 $38M
Cash And Equivalents FY 2024 · Dec 31, 2023 $352M
Current Liabilities FY 2024 · Dec 31, 2023 $1.24B
Total Liabilities FY 2024 · Dec 31, 2023 $8.14B
Current Assets FY 2024 · Dec 31, 2023 $3.41B
Total Assets FY 2024 · Dec 31, 2023 $14.36B
Shares Diluted FY 2024 · Dec 31, 2022 488.3M sh
Capex restated FY 2024 · Dec 31, 2022 $171M
Operating Cash Flow FY 2024 · Dec 31, 2022 $452M
Eps Diluted FY 2024 · Dec 31, 2022 −$0.16
Eps Basic FY 2024 · Dec 31, 2022 −$0.16
Sga Expense FY 2024 · Dec 31, 2022 $1.27B
Rd Expense FY 2024 · Dec 31, 2022 $321M
Net Income FY 2024 · Dec 31, 2022 −$78M
Cost Of Revenue FY 2024 · Dec 31, 2022 $1.91B
Revenue FY 2024 · Dec 31, 2022 $4.41B
Stockholders Equity restated FY 2024 · Dec 31, 2021 $7.51B